Atosiban | High Purity Peptide | CAS No. 90779-69-4

Atosiban (CAS No. 90779-69-4) is a synthetic cyclic nonapeptide functioning as a potent oxytocin receptor antagonist. It competitively inhibits the binding of oxytocin to its receptor, thereby reducing uterine contractions and suppressing preterm labor. Owing to its excellent receptor selectivity and favorable safety profile, Atosiban has been widely used in obstetric medicine as a tocolytic agent. With advanced solid-phase peptide synthesis (SPPS) technology and high-purity purification processes, our Atosiban offers consistent batch quality and superior stability, making it ideal for both pharmaceutical manufacturing and biomedical research applications.

- Highly pure and stable peptide synthesized using advanced SPPS technology.
- Selective oxytocin and vasopressin receptor antagonist.
- Clinically used for the treatment of preterm labor (tocolytic agent).
- Extensively applied in pharmaceutical research and drug development.
- Suitable for both clinical research and reference standard applications.

Atosiban is produced in a GMP-compliant facility using solid-phase peptide synthesis (SPPS) followed by HPLC purification and lyophilization. Each batch undergoes rigorous analytical testing including HPLC, MS, and NMR to ensure identity, purity, and consistency.

Our manufacturing facilities are ISO9001 and GMP certified. All peptide products are provided with comprehensive documentation including Certificate of Analysis (COA), MSDS, and analytical data. Third-party testing reports are available upon request.

We continuously invest in R&D for peptide synthesis and formulation technologies, ensuring the highest quality standards for our pharmaceutical-grade peptides. For more peptide innovations, please visit our official website.

Hot Tags: atosiban | high purity peptide | cas no. 90779-69-4, China atosiban | high purity peptide | cas no. 90779-69-4 manufacturers, suppliers